Oseltamivir is widely supported by clinical literature as an effective medication for the prevention and chemoprophylaxis of influenza when administered prior to viral exposure or symptom onset.
The provided papers consistently reference or demonstrate the efficacy of oseltamivir for influenza prophylaxis before symptom onset or exposure, particularly in high-risk populations, with no papers refuting this prophylactic utility.